# BIO|MASTER.CSP Study

> **NCT06620237** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Biotronik SE & Co. KG** · enrollment: 152 (estimated)

## Conditions studied

- Cardiac Pacing, Artificial
- Cardiac Pacemaker, Artificial
- Cardiac Resynchronization Therapy Devices
- Bradycardia
- Conduction Disorder
- Conduction Defect, Cardiac
- Heart Failure

## Interventions

- **DEVICE:** Implantation of the Solia CSP S pacing lead for LBBAP

## Key facts

- **NCT ID:** NCT06620237
- **Lead sponsor:** Biotronik SE & Co. KG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-10-04
- **Primary completion:** 2026-04
- **Final completion:** 2027-09
- **Target enrollment:** 152 (ESTIMATED)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06620237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06620237, "BIO|MASTER.CSP Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06620237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*